Interestingly, a significantelevation in plasma, but not tissue, ET-1 levels was observed in week 16, therebyindicating enhanced ET-1 release in the later stages of disease progression [13].In the context of human trials, data on the pathophysiological role of ET-1 inessential hypertension are limited. The gene discussed is EDN1; the disease is Hypertension.